Thyroid FNA Cytology : Differential Diagnoses and Pitfalls /
Thyroid FNA Cytology : Differential Diagnoses and Pitfalls / [E-Book]
- 3rd ed. 2023.
- XXI, 837 p. 573 illus., 546 illus. in color. online resource.
I: Why Are There Significant Differences Among Us in Thyroid Nodule Practices? -- 1. Addressing the Impact of International Variation in Thyroid Cytology. Which Reporting System is best for Patients? -- 2. Diagnostic Criteria of Papillary Thyroid Carcinoma (PTC)-Type Nuclear Features Impacting Thyroid Fine Needle Aspiration (FNA) Cytology -- 3. Differences among thyroid FNA practices elucidated by meta-analyses of the literature -- 4. International Comparison Study of Thyroid Fine Needle Aspiration (FNA) Cytology Reporting System -- 5. Thyroid FNA terminology: Progress Towards a Single Unified International System for Thyroid FNA Reporting -- II: Reporting Systems of Thyroid FNA Cytology -- 6. Introduction to the third edition of the Bethesda System for Reporting Thyroid Cytopathology -- 7. The 2014 Italian Reporting System For Thyroid Cytology: Present and Future -- 8. The UK Royal College of Pathologists (RCPath) Thy Terminology for Reporting Thyroid FNA Cytology -- 9. Australian System forReporting Thyroid Cytology -- 10. The Japanese System Recommended by the Japan Thyroid Association -- 11. Risk Classification of Follicular Pattern Lesions in Thyroid FNA -- 12. Japanese Reporting System for Thyroid Aspiration Cytology (JRSTAC) -- 13. Clinical Management for Follicular Neoplasm without Molecular Testing -- III: Classification of Thyroid Tumors -- 14. Histological Classification of Thyroid Tumors by the new 5th Edition WHO Classification -- 15. Low-risk Neoplasms in the 5th Edition of the WHO Classification of Thyroid Tumors -- 16. Clinically Insignificant Papillary Thyroid Carcinoma and Self-limiting Carcinoma that do not Harm Patients -- 17. Whole Tumor Capsule Is Prognostic Of Very Good Outcome In The Classical Variant Of Papillary Thyroid Cancer -- 18. A Framework For Approaching Cytologically Indeterminant Thyroid Nodules With Ras Mutations: A North American Perspective -- 19. Clinical Advantages and Limitations of Tumours Displaying Minimal and Extensive Vascular Invasion.-20. High-grade follicular cell-derived non-anaplastic thyroid carcinomas -- 21. Molecular classification of thyroid tumors and key molecular features to identify high-grade thyroid carcinomas -- IV: Criteria for Each Cytological Category -- 22. Specimen Adequacy and Non-diagnostic Thyroid Nodules -- 23. Cyst Fluid Only Samples -- 24. Cytology of benign thyroid aspirates -- 25. AUS/FLUS in the third edition Bethesda system -- 26. Cytological Diagnosis of FN Nodules -- 27. Diagnostic Criteria of Suspicious for Malignancy -- 28. Cytological Diagnoses of Malignancy and Nuclear Features of PTC -- V: Cytological Features of Thyroid Lesions -- 29. Diagnostic Clues for Thyroid Aspiration Cytology -- 30. False Positive in Thyroid FNA: Causes and How to Avoid Them -- 31. Papillae in thyroid aspirates -- 32. Papillary thyroid carcinoma on LBC preparation -- 33. Spindle cells in thyroid aspirates -- VI: Benign Lesions, Differential Diagnoses and Pitfalls -- 34. Thyroglossal Duct Cyst and Other Ectopic Thyroid Tissues in the Neck -- 35. Benign follicular pattern lesions (nodular hyperplasia) -- 36. Infectious Thyroiditis -- 37. Diagnostic Considerations for Thyroid Nodules in Graves' Disease -- 38. Subacute Thyroiditis or Papillary Carcinoma -- 39. Hashimoto's Thyroiditis or Papillary Carcinoma -- VII: Low Risk Neoplasms, Differential Diagnoses and Pitfalls -- VII: Low Risk Neoplasms, Differential Diagnoses and Pitfalls -- 40. NIFTP in Asian practice -- 41. Role of FNA Cytology in Preoperative Prediction of NIFTP - Practical Experiences in North America -- 42. Hyalinizing Trabecular Tumor -- VIII: Papillary Thyroid Carcinoma, Differential Diagnoses and Pitfalls -- 43. Cystic Papillary Thyroid Carcinoma -- 44. Tall Cell Variant of Papillary Thyroid Carcinoma -- 45. Papillary carcinoma, Columnar Cell Variant---Diagnostic Pitfalls and Differential Diagnoses -- 46.Hobnail Papillary Thyroid Carcinoma -- 47. Solid/Trabecular Variant of Papillary Thyroid Carcinoma -- 48. Aggressive Subtypes of PTC, How to Handle themin FNA Cytology -- IX: High-Grade Carcinomas, Differential Diagnoses and Pitfalls -- 49. High-grade follicular-derived Carcinomas in FNA Cytology -- 50. Poorly Differentiated Carcinoma and Anaplastic Carcinoma of the Thyroid -- 51. Anaplastic Thyroid Carcinoma -- 52. Metastasis to Thyroid -- X: Other Thyroid Lesions, Differential Diagnoses and Pitfalls -- 53. Cribriform-Morular Thyroid Carcinoma -- 54. Oncocytic Cell Neoplasms in Hematoxylin-Eosin-Stained Samples -- 55. H�rthle Cell Neoplasms in Papanicolaou- and Romanowsky-Stained Specimens -- 56. Medullary (C Cell) Thyroid Carcinoma or Oxyphilic Follicular Neoplasms -- 57. Diagnosis of Medullary (C cell) Thyroid Carcinoma -- 58. Primary Thyroid Lymphoma -- 59. Rare Hematolymphoid Neoplasms of the Thyroid -- 60. Intrathyroid Thymic Carcinoma -- 61. Parathyroid Adenoma and Its Differential Diagnoses -- XI: How to Improve Diagnostic Performance in Thyroid FNA Cytology -- 62. How to Prepare Optimal FNA Samples -- 63. Staining Methods in Thyroid Cytology.-64. Fine Needle Aspiration Biopsy Complications -- 65. Liquid-Based Cytology Technique for Thyroid Cytology -- 66. Rapid on-site evaluation -- 67. Mobile rapid on-site evaluation -- 68. Low Cellularity Thyroid Fine Needle Aspiration Specimens: Differential Diagnosis, the Role of Ancillary Testing and Associated Diagnostic Challenges -- 69. The role of repeat FNA in indeterminate thyroid nodules -- 70. Frozen section and intraoperative imprint cytology -- 71. Core Needle Biopsy for the Diagnosis of Thyroid Nodules: Pathologic Aspects -- 72. Biochemical Test of Fine-needle Aspirate as an Adjunct to Cytological Diagnosis in Patients with Thyroid Cancer or Primary Hyperparathyroidism -- 73. Quality Control for Cytology Laboratory in the USA -- 74. Infection control in cytology practice and the COVID19 pandemic -- XII: Immunohistochemistry in Thyroid Nodule Practice -- 75. Cell blocks in cytopathology and its role in evaluation of thyroid aspirates -- 76. European experience and recommendations on immunohistochemistry on cytology specimens -- 77. Application of Immunocytochemistry in Thyroid Aspiration Cytology -- XIII: Molecular Tests in Thyroid Nodule Practice -- 78. Practice of Molecular Detection of Thyroid Fine Needle Aspiration Specimen in China -- 79. Experience in Molecular Testing Using FNA Cytology in EU Countries -- 80. Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada -- 81. Thyroid Fine Needle Aspiration Cytology Molecular Testing in the USA -- 82. Molecular Target Therapy for Pathologists in Advanced Thyroid Carcinoma -- XIV: Image Technology in Thyroid Nodule Practice -- 83. Pathologic Basis for Thyroid Ultrasound -- 84. Ultrasonography of the thyroid gland -- 85. Nuclear imaging of the thyroid gland -- XV: Clinical Guidelines in Thyroid Nodule Practice -- 86. International Comparison Study of Clinical Guidelines for Thyroid Nodule Evaluation -- 87. How to Follow FNA-confirmed Benign Thyroid Nodules -- 88. Management of PapillaryMicrocarcinoma of the Thyroid -- 89. Active surveillance of low-risk thyroid carcinoma in Western practice -- XVI: Thyroid Carcinoma in Children and Young Adults -- 90. Thyroid Nodules in Children and Adolescents -- 91. Thyroid Carcinoma of Young Adults and Children -- 92. The role of thyroid FNA cytology in pediatric malignant lesions: Case illustrations and literature review -- XVII: Patient Oriented Thyroid Nodule Practice -- 93. One Stop Clinic for Thyroid Nodules -- 94. Caring for Patients with Thyroid Nodules: Preventing Overdiagnosis as a Harm of FNA Cytological Examinations -- 95. Consideration of Patients' Viewpoint and the Role of Pathologists in Reporting Diagnosis of Thyroid Carcinomas.
This is the third edition of a well-received book that recapitulates the thyroid fine-needle aspiration (FNA) cytology. It covers the basics and critical principles of thyroid cytopathology, addresses technical aspects, and presents the latest breakthrough events in the field, including the new editions of the WHO classification of thyroid tumors and the Bethesda system for reporting thyroid cytopathology. Thyroid FNA Cytology, The Third Edition is a practical handbook for cytopathologists, pathologists, cytotechnologists, endocrinologists, thyroid surgeons, radiologists, thyroid cancer patients, and their families. This edition covers more topics than the previous editions and invites authors from 20 countries from Asia, Europe, and America. It should serve as an individualized guide to readers practicing in various geographic areas with different medical settings and social resources. The book provides multiple chapters on differential diagnosis and pitfalls to show the unique approaches in many countries. The book will broaden their perspectives and serve as a foundation for further advancement in this field.
9789819967827
10.1007/978-981-99-6782-7 doi
Internal medicine.
Pathology.
Endocrinology.
Internal Medicine.
Pathology.
Endocrinology.
I: Why Are There Significant Differences Among Us in Thyroid Nodule Practices? -- 1. Addressing the Impact of International Variation in Thyroid Cytology. Which Reporting System is best for Patients? -- 2. Diagnostic Criteria of Papillary Thyroid Carcinoma (PTC)-Type Nuclear Features Impacting Thyroid Fine Needle Aspiration (FNA) Cytology -- 3. Differences among thyroid FNA practices elucidated by meta-analyses of the literature -- 4. International Comparison Study of Thyroid Fine Needle Aspiration (FNA) Cytology Reporting System -- 5. Thyroid FNA terminology: Progress Towards a Single Unified International System for Thyroid FNA Reporting -- II: Reporting Systems of Thyroid FNA Cytology -- 6. Introduction to the third edition of the Bethesda System for Reporting Thyroid Cytopathology -- 7. The 2014 Italian Reporting System For Thyroid Cytology: Present and Future -- 8. The UK Royal College of Pathologists (RCPath) Thy Terminology for Reporting Thyroid FNA Cytology -- 9. Australian System forReporting Thyroid Cytology -- 10. The Japanese System Recommended by the Japan Thyroid Association -- 11. Risk Classification of Follicular Pattern Lesions in Thyroid FNA -- 12. Japanese Reporting System for Thyroid Aspiration Cytology (JRSTAC) -- 13. Clinical Management for Follicular Neoplasm without Molecular Testing -- III: Classification of Thyroid Tumors -- 14. Histological Classification of Thyroid Tumors by the new 5th Edition WHO Classification -- 15. Low-risk Neoplasms in the 5th Edition of the WHO Classification of Thyroid Tumors -- 16. Clinically Insignificant Papillary Thyroid Carcinoma and Self-limiting Carcinoma that do not Harm Patients -- 17. Whole Tumor Capsule Is Prognostic Of Very Good Outcome In The Classical Variant Of Papillary Thyroid Cancer -- 18. A Framework For Approaching Cytologically Indeterminant Thyroid Nodules With Ras Mutations: A North American Perspective -- 19. Clinical Advantages and Limitations of Tumours Displaying Minimal and Extensive Vascular Invasion.-20. High-grade follicular cell-derived non-anaplastic thyroid carcinomas -- 21. Molecular classification of thyroid tumors and key molecular features to identify high-grade thyroid carcinomas -- IV: Criteria for Each Cytological Category -- 22. Specimen Adequacy and Non-diagnostic Thyroid Nodules -- 23. Cyst Fluid Only Samples -- 24. Cytology of benign thyroid aspirates -- 25. AUS/FLUS in the third edition Bethesda system -- 26. Cytological Diagnosis of FN Nodules -- 27. Diagnostic Criteria of Suspicious for Malignancy -- 28. Cytological Diagnoses of Malignancy and Nuclear Features of PTC -- V: Cytological Features of Thyroid Lesions -- 29. Diagnostic Clues for Thyroid Aspiration Cytology -- 30. False Positive in Thyroid FNA: Causes and How to Avoid Them -- 31. Papillae in thyroid aspirates -- 32. Papillary thyroid carcinoma on LBC preparation -- 33. Spindle cells in thyroid aspirates -- VI: Benign Lesions, Differential Diagnoses and Pitfalls -- 34. Thyroglossal Duct Cyst and Other Ectopic Thyroid Tissues in the Neck -- 35. Benign follicular pattern lesions (nodular hyperplasia) -- 36. Infectious Thyroiditis -- 37. Diagnostic Considerations for Thyroid Nodules in Graves' Disease -- 38. Subacute Thyroiditis or Papillary Carcinoma -- 39. Hashimoto's Thyroiditis or Papillary Carcinoma -- VII: Low Risk Neoplasms, Differential Diagnoses and Pitfalls -- VII: Low Risk Neoplasms, Differential Diagnoses and Pitfalls -- 40. NIFTP in Asian practice -- 41. Role of FNA Cytology in Preoperative Prediction of NIFTP - Practical Experiences in North America -- 42. Hyalinizing Trabecular Tumor -- VIII: Papillary Thyroid Carcinoma, Differential Diagnoses and Pitfalls -- 43. Cystic Papillary Thyroid Carcinoma -- 44. Tall Cell Variant of Papillary Thyroid Carcinoma -- 45. Papillary carcinoma, Columnar Cell Variant---Diagnostic Pitfalls and Differential Diagnoses -- 46.Hobnail Papillary Thyroid Carcinoma -- 47. Solid/Trabecular Variant of Papillary Thyroid Carcinoma -- 48. Aggressive Subtypes of PTC, How to Handle themin FNA Cytology -- IX: High-Grade Carcinomas, Differential Diagnoses and Pitfalls -- 49. High-grade follicular-derived Carcinomas in FNA Cytology -- 50. Poorly Differentiated Carcinoma and Anaplastic Carcinoma of the Thyroid -- 51. Anaplastic Thyroid Carcinoma -- 52. Metastasis to Thyroid -- X: Other Thyroid Lesions, Differential Diagnoses and Pitfalls -- 53. Cribriform-Morular Thyroid Carcinoma -- 54. Oncocytic Cell Neoplasms in Hematoxylin-Eosin-Stained Samples -- 55. H�rthle Cell Neoplasms in Papanicolaou- and Romanowsky-Stained Specimens -- 56. Medullary (C Cell) Thyroid Carcinoma or Oxyphilic Follicular Neoplasms -- 57. Diagnosis of Medullary (C cell) Thyroid Carcinoma -- 58. Primary Thyroid Lymphoma -- 59. Rare Hematolymphoid Neoplasms of the Thyroid -- 60. Intrathyroid Thymic Carcinoma -- 61. Parathyroid Adenoma and Its Differential Diagnoses -- XI: How to Improve Diagnostic Performance in Thyroid FNA Cytology -- 62. How to Prepare Optimal FNA Samples -- 63. Staining Methods in Thyroid Cytology.-64. Fine Needle Aspiration Biopsy Complications -- 65. Liquid-Based Cytology Technique for Thyroid Cytology -- 66. Rapid on-site evaluation -- 67. Mobile rapid on-site evaluation -- 68. Low Cellularity Thyroid Fine Needle Aspiration Specimens: Differential Diagnosis, the Role of Ancillary Testing and Associated Diagnostic Challenges -- 69. The role of repeat FNA in indeterminate thyroid nodules -- 70. Frozen section and intraoperative imprint cytology -- 71. Core Needle Biopsy for the Diagnosis of Thyroid Nodules: Pathologic Aspects -- 72. Biochemical Test of Fine-needle Aspirate as an Adjunct to Cytological Diagnosis in Patients with Thyroid Cancer or Primary Hyperparathyroidism -- 73. Quality Control for Cytology Laboratory in the USA -- 74. Infection control in cytology practice and the COVID19 pandemic -- XII: Immunohistochemistry in Thyroid Nodule Practice -- 75. Cell blocks in cytopathology and its role in evaluation of thyroid aspirates -- 76. European experience and recommendations on immunohistochemistry on cytology specimens -- 77. Application of Immunocytochemistry in Thyroid Aspiration Cytology -- XIII: Molecular Tests in Thyroid Nodule Practice -- 78. Practice of Molecular Detection of Thyroid Fine Needle Aspiration Specimen in China -- 79. Experience in Molecular Testing Using FNA Cytology in EU Countries -- 80. Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada -- 81. Thyroid Fine Needle Aspiration Cytology Molecular Testing in the USA -- 82. Molecular Target Therapy for Pathologists in Advanced Thyroid Carcinoma -- XIV: Image Technology in Thyroid Nodule Practice -- 83. Pathologic Basis for Thyroid Ultrasound -- 84. Ultrasonography of the thyroid gland -- 85. Nuclear imaging of the thyroid gland -- XV: Clinical Guidelines in Thyroid Nodule Practice -- 86. International Comparison Study of Clinical Guidelines for Thyroid Nodule Evaluation -- 87. How to Follow FNA-confirmed Benign Thyroid Nodules -- 88. Management of PapillaryMicrocarcinoma of the Thyroid -- 89. Active surveillance of low-risk thyroid carcinoma in Western practice -- XVI: Thyroid Carcinoma in Children and Young Adults -- 90. Thyroid Nodules in Children and Adolescents -- 91. Thyroid Carcinoma of Young Adults and Children -- 92. The role of thyroid FNA cytology in pediatric malignant lesions: Case illustrations and literature review -- XVII: Patient Oriented Thyroid Nodule Practice -- 93. One Stop Clinic for Thyroid Nodules -- 94. Caring for Patients with Thyroid Nodules: Preventing Overdiagnosis as a Harm of FNA Cytological Examinations -- 95. Consideration of Patients' Viewpoint and the Role of Pathologists in Reporting Diagnosis of Thyroid Carcinomas.
This is the third edition of a well-received book that recapitulates the thyroid fine-needle aspiration (FNA) cytology. It covers the basics and critical principles of thyroid cytopathology, addresses technical aspects, and presents the latest breakthrough events in the field, including the new editions of the WHO classification of thyroid tumors and the Bethesda system for reporting thyroid cytopathology. Thyroid FNA Cytology, The Third Edition is a practical handbook for cytopathologists, pathologists, cytotechnologists, endocrinologists, thyroid surgeons, radiologists, thyroid cancer patients, and their families. This edition covers more topics than the previous editions and invites authors from 20 countries from Asia, Europe, and America. It should serve as an individualized guide to readers practicing in various geographic areas with different medical settings and social resources. The book provides multiple chapters on differential diagnosis and pitfalls to show the unique approaches in many countries. The book will broaden their perspectives and serve as a foundation for further advancement in this field.
9789819967827
10.1007/978-981-99-6782-7 doi
Internal medicine.
Pathology.
Endocrinology.
Internal Medicine.
Pathology.
Endocrinology.
London Health Libraries Consortium Privacy notice and Membership terms and conditions